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ABSTRACT 
 
Microfluidics for Single Molecule Detection and Material Processing. (August 2012) 
Sung Min Hong, B.A., Kyung Hee University; 
M.S., Kyung Hee University 
Chair of Advisory Committee: Dr. Jun Kameoka 
 
In the cancer research, it is important to understand protein dynamics which are 
involved in cell signaling. Therefore, particular protein detection and analysis of target 
protein behavior are indispensable for current basic cancer research. However, it usually 
performed by conventional biochemical approaches, which require long process time 
and a large amount of samples. We have been developed the new applications based on 
microfluidics and Raster image Correlation spectroscopy (RICS) techniques. 
A simple microfluidic 3D hydrodynamic flow focusing device has been 
developed for quantitative determinations of target protein concentrations. The analyte 
stream was pinched not only horizontally, but also vertically by two sheath streams by 
introducing step depth cross junction structure. As a result, a triangular cross-sectional 
flow profile was formed and the laser was focused on the top of the triangular shaped 
analyte stream. Through this approach, the target protein concentration was successfully 
determined in cell lysate samples. 
The RICS technique has been applied to characterize the dynamics of protein 53 
(p53) in living cells before and after the treatment with DNA damaging agents. P53 
 iv
tagged with Green Fluores-cent Protein (GFP) were incubated with and without DNA 
damaging agents, cisplatin or eptoposide. Then, the diffusion coefficient of GFP-p53 
was determined by RICS and it was significantly reduced after the drug treatment while 
that of the one without drug treatment was not. It is suggested that the drugs induced the 
interaction of p53 with either other proteins or DNA. This result demonstrates that RICS 
is able to detect protein-protein or protein-DNA interactions in living cells and it may be 
useful for the drug screening. 
As another application of microfluidics, an integrated microfluidic platform was 
developed for generating collagen microspheres with encapsulation of viable cells. The 
platform integrated four automated functions on a microfluidic chip, (1) collagen 
solution cooling system, (2) cell-in-collagen microdroplet generation, (3) collagen 
microdroplet polymerization, and (4) incubation and extraction of the microspheres. This 
platform provided a high throughput and easy way to generate uniform dimensions of 
collagen microspheres encapsulating viable cells that were able to proliferate for more 
than 1 week.
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RICS    Raster Image Correlation Spectroscope 
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1. INTRODUCTION 
Breast cancer is a major disease in women in the United States. Annually, around 
205,000 women are suffering from breast cancer.1 Various techniques have been 
developed to reveal tumor-related proteins along the signal pathways, but many details 
still remain unclear due to limitations of current techniques.2, 3 
In recent years, microfluidics has been extensively studied to handle small 
volume of samples. In order to control micro volume of fluid, micrototal analysis system 
(μ-TAS) or lab-on-a-chip (LOC) concepts have been developed and integrated in the 
various fields of biological and chemical assays.4, 5 Hydrodynamic focusing is the one of 
efficient way of producing uniform sample stream in microfluidic channels by confining 
sample flow laterally via shear force of sheath flows. This techniques are widely used in 
the application of micro-flow cytometry or drug delivery system, such as single 
molecule reaction,6 microfluidic cell sorter,7 cell patterning,8 and generation of 
monodisperse particles or polygonal water droplets.9, 10  Conventionally, sample stream 
was formed a thin rectangular cross-sectional profile by neighboring sheath flows due to 
the horizontal shear force. While the horizontal flow confinement can be relatively easy 
to be achieved, vertical hydrodynamic focusing requires additional compartments or 
multiple protocols. For instance, some of 2D hydrodynamic focusing devices have been 
introduced so far to improve the vertical resolution.10-13  
 
 
______ 
This?????????tation follows the style of Applied Physics Letters. 
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Although these devices allow horizontal and vertical focusing of sample stream, 
complex fabrication protocol and multiple PDMS layers assembly are necessary to 
fabricate devices. 
In this dissertation, new approaches of multidisciplinary efforts were presented: 
the development of novel 3D hydrodynamic focusing for accurate quantitative protein 
detection, Raster Image Correlation Spectroscope (RICS) as a tool of drug screening, 
and a development of microfluidics platform for collagen microspheres generation 
(Figure 1). 
 
 
Figure 1. An overview of research 
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Specifically, Section 2 describes the simple structure of 3D hydrodynamic 
focusing device with step depth junction, which is able to demonstrate vertical and 
horizontal flow confinement effects. This confinement effect was experimentally 
confirmed by using a confocal microscope. Compared to other techniques, our device 
has several advantages, including straightforward structure (one sheath and sample inlet) 
and fast fabrication method via standard photolithography. In addition, microfluidic 
device is able to control the cross-sectional profile of sample stream by changing sheath 
and sample flow rates. 
The work from Section 3 extends the RICS as a tool of drug screening. RICS can 
analyze the spatial fluctuation in the fluorescence signal, which is generated by the 
movement of fluorescence labeled molecules, to obtain molecular diffusion information. 
We have investigated the effects of DNA damaging agents, cisplatin and etoposide, on 
p53 dynamics in living HeLa cells by using RICS. After the drug treatment, the 
significant reductions of p53 mobility were observed compared to the one without drug 
treatment. Both cisplatin and etoposide induced DNA damage that stabilized and 
activated p53, resulting in the formation of the DNA-p53-transcription co-factors 
complex. Therefore, the results obtained by RICS explain the p53 dynamics in living 
cells. 
 In the Section 4, an integrated high-throughput microfluidic platform is 
introduced to generate collagen microspheres of uniform size and shape with high cell 
viability. Since this platform integrated the collagen microdroplet generation and the 
gelation functions on a chip, the time lag between these steps was sufficiently short so as 
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to avoid coalescence of microdroplets, resulting in highly uniform microspheres. Further, 
a novel microfluidic extraction approach was employed that considerably improved cell 
viability over that obtained with centrifugal extraction. 
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2. MICROFLUIDIC 3D HYDRODYNAMIC FOCUSING
FOR RAPID PROTEIN CONCENTRATION ANALYSIS 
 
2.1 Introduction 
Over the past decade, single molecule detection (SMD) techniques have been 
incorporated with microfluidics systems14-16 and studied for single molecule detections 
for DNA and fluorescent dyes.17-19 For instance, DNA fragment sizing was demonstrated 
by using fluorescent signal detection in fused silica microfluidic channels and a high 
numerical aperture (NA) microscope objective lens.20-22 DNAs were stained with the 
dimeric fluorescent intercalating dyes and electrokinetically flowed into the detection 
channel. Whenever DNA molecules passed through the detection spot, fluorescent 
photon was detected by the avalanche photo diode (APD). Since long DNA fragments 
were able to carry more fluorescent tags, length of DNAs could be identified by their 
fluorescent intensities from Gaussian photon histogram. Recently, these microfluidic 
SMD techniques have been expanded to the protein detection in cell lysate solutions.23, 24 
Although there were some successful single protein detections, fused silica based 
microfluidic device had difficulty to characterize protein concentration because of the 
fluctuation of electroosmotic flow (EOF) velocity. Proteins tend to adsorb on the surface 
of fused silica that caused surface charge instability. 
 
______ 
Reprinted with permission from “Microfluidic Three-dimensional Hydrodynamic Flow 
Focusing for the Rapid Protein Concentration Analysis”, by Sungmin Hong, Pei-Hsiang 
Tsou, Chao-Kai Chou et al. Biomicrofluidics 6, 204132 (2012). Copyright 2012, 
American Institute of Physics. 
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The conventional 2D capillary flow focusing system with 50-200 μm width of 
pinched analyte flow have been developed for single molecular detection of fluorescent 
dye molecules.25-27 In these approaches, low numerical aperture (NA) objective lens and 
high power laser were used to form a large laser spot to cover the width of capillary. On 
the other hand, larger laser spot would be a cause of the target molecules bleaching 
because of the longer residual time in the laser spot. In case of cell lysate sample 
solution, the target molecule signals would be inhibited by the auto-fluorescent from 
other molecules contained in a large detection volume.  
 
 
Figure 2. The distorted histograms from a wide fluidic channel. (a) no diffusion, (b) weak diffusion, (c) 
strong diffusion, (d) photonic noise in case of strong diffusion.28 
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As a result, the photon burst histogram was disturbed from normal Gaussian 
profile and provided inaccurate concentration measurements (Figure 2). Recently, the 
capillary flow focusing technique was implemented to microfluidics and has detected 
single molecules and fluorescent dyes.29-33 The dimensions of analyte flow in 
microfluidic device were reduced to 20-50μm, but detection volumes were not 
significantly reduced. Therefore, the auto-fluorescent was influenced to photon burst 
histograms. The comparison of conventional technique (Western Blot) and our technique 
is shown in Table 1.  
 
Table 1. Comparison of SMD techniques. 
 Western Blot Micro-channel SMD techniques 
3D Hydrodynamic 
Focusing 
Signal 
source Ensemble of  molecules 
Single molecule Single molecule 
Sensitivity Nano-gram Picomolar Picomolar 
Processing 
time 3 days 2-3 min 2-3 min 
Cost High High (channel fabrication cost) Low 
Quantitative 
information No Yes Yes 
Analysis 
method 
Existence 
(band width &
brightness) 
Photon counts 
(distorted histogram) 
Photon counts 
(Gaussian histogram) 
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So far, there have been no reports of protein concentration determination by 
using single molecule detection system. Accurate determination of protein concentration 
is important in cancer research to understand complex process of development and 
progression. Also, the Myc/MAX protein complex is a transcription regulator that 
controls various physiological functions such as cell proliferation, differentiation, 
metabolism and apoptosis.34 More importantly, Myc/MAX complex are frequently 
upregulated in human cancer and plays a critical role in cancer development and 
progression.34 Myc and MAX form a heterodimer and directly binds to specific DNA 
sequences to activate or repress gene transcription.35 The expression levels of Myc and 
MAX in cells are critical determinants for multiple cellular functions. Therefore, in the 
present study, we chose the MAX protein as a model to further develop a novel protein 
detection system. This is the first time to determine the protein concentration by 
counting each protein. In order to detect accurate protein concentration, normal Gaussian 
distribution of photon burst distribution is necessary.28 We have developed simple 3D 
hydrodynamic focusing devices to overcome current problems and improve the SMD 
accuracy for the protein concentration analysis. Our design can provide Gaussian photon 
burst distributions to determine the protein concentration by reducing significantly the 
detection volume. 
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2.2 Hydrodynamic Focusing Techniques 
Several techniques of two dimensional (2D) Hydrodynamic Focusing have been 
introduced since 1998.36-39 2D hydrodynamic focusing technique allowed the sample to 
position on the center of channel. As a result, sample dispersion was minimized. 
However, it is difficult to detect a single molecule using conventional 2D hydrodynamic 
focusing because the conventional 2D hydrodynamic focusing in microfluidic channel 
formed a thin rectangular cross-sectional profile as shown in Figure 3. The height of 
fluidic flow is same as the vertical height of channel dimension. Therefore, two or more 
target molecules were detected at the detection volume due to the lack of vertical 
resolution. 
In order to overcome the weakness of 2D hydrodynamic focusing, several 3D 
hydrodynamic focusing devices have been introduced to improve the vertical 
resolution.10, 11, 40-43 Although these devices allow horizontal and vertical focusing of 
sample stream, some of limitations still exist such as vertical position control problem44 
and multiple PDMS layers assembly (Figure 4).45, 46 Although, Mao et al. proposed a 
single layer 3D hydrodynamic focusing technique.47 It requires high flow velocity to 
make Dean flow, which makes a difficulty of vertical position controlling. 
 
 
 10
 
Figure 3. Confocal scanning microscopy images of typical 2D hydrodynamic focusing at the different 
flow conditions.36  
 11
 
Figure 4. An example of procedure of the layer assembly for the 3D hydrodynamic focusing chip. 46 
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2.3 Microfluidic Channel Fabrication 
Microfluidic devices were fabricated on poly (dimethylsiloxane) substrate 
(PDMS; Dow Corning, Midland, MI) by standard micro-molding procedures.48 Two 
lithographic processes were used to fabricate a mold of the shallow and deep channels 
on a silicon wafer separately. SU-8 2010 photoresist (Microchem Corp., Newton, MA) 
was spin-coated with the thickness of 10 m on a silicon wafer and exposed by EV620 
contact aligner. After the development process, the shallow channel was formed. Then, 
50 m thickness of SU-8 2050 (Microchem Corp., Newton, MA) was spin-coated on the 
smaller channel patterned silicon surface.  
 
 
Figure 5. The schematic diagram of microfluidic channel. Chip-level view of the 3D hydrodynamic 
focusing device. 
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The second mask was aligned with the alignment markers made by the first 
lithography process. At this process, the shallow channel was connected to the deep 
channels to form the step junction structure. After the exposure and development 
processes, the micro-mold for microfluidic devices was made on the silicon wafer. Then, 
uncured PDMS mixture was dispensed over the lithographically patterned silicon mold 
and cured at 65 C° for 2 hours. Then, cured PDMS substrate was peeled off from the 
master silicon mold. The PDMS microchannel substrate was bonded to quartz cover 
slide glass (170 m thickness) by oxygen plasma treatment for 30 seconds. Since most 
proteins are positively charged at pH 7, the PDMS channel was coated by 
polyethyleneimine (PEI), which is a positively charged polymer, to prevent protein 
absorption on channel wall. A schematic diagram of the 3D microfluidic flow focusing 
device was shown in Figure 5.  
 
 
Figure 6. The SEM image of the cross junction area (scale bar: 10 μm). 
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This device mainly consisted of two different depths and widths of 
microchannels. The shallow channel (10 μm in depth and width) was connected with the 
deep sheath inlet channels (50 μm in depth and width) at the cross junction. Sheath and 
analyte streams were delivered into the main detection channel (50 μm in depth and 
width) by two separate syringe pumps (11 plus, Harvard Apparatus, Cambridge, MA) at 
various flow rates. A scanning electron microscope (SEM) image showed the sheath, the 
detection, and the analyte channels at the cross junction area (Figure 6). 
 
2.4 Photon Burst Detection System
The microfluidic device was placed on the Nikon 2000 Inverted microscope 
stage as shown in Figure 7. Analyte and sheath streams were delivered through their 
inlets and 375 nm laser (16 mW) was focused through 60X water immersion objective 
lens at the top of the triangular shaped analyte stream, which was about 15 μm above the 
bottom of the main channel.  The radius of laser spot was calibrated to 1.1 μm. whenever 
analyte molecules passed through the detection spot; they were excited and emitted 
fluorescent photon bursts. 
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Figure 7. Experimental setup: syringe pumps delivered analyte and sheath flows to the microfluidic 
device. QDs were excited by 375 nm laser. Emitted fluorescent signals were detected by APD in photon 
burst detection system. 
 
For all detections, five sets of raw photon burst data were recorded for 10 
seconds each. The recorded raw photon burst data was smoothened by fast Fourier 
transform (FFT) filter49 and the individual photon burst peaks higher than the noise level, 
which was determined by the blank solution, were defined as single molecule peaks. 
These peaks were plotted on the photon burst histogram which indicated the number of 
target molecules detected (Figure 8).  
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Figure 8. An example of FFT filtering of photon burst data. Upper: raw photon burst profile. Lower: 
photon burst signal profile after the FFT filtering process.10  
 
2.5 Sample Protein Preparation 
Quantum dot (QD)-conjugated anti-rabbit IgG secondary antibody was 
purchased from Invitrogen, Inc. In this solution, 1 M concentration of QD525-antibody 
was suspended in 1 M betaine, 50 mM borate, pH 8.3 with 0.05% sodium azide solution. 
This solution was diluted with phosphate buffered saline (PBS) to a concentrations of 10 
pM, 100 pM and 1 nM. HA-MAX expression plasmid or empty vector was transiently 
transfected in human embryonic kidney 293 (HEK-293) cells by using liposome. 24 
hours after transfection, the cells with or without HA-MAX expression were harvested 
and lysed in RIPA buffer (50 mM Tris-HCl, 1% NP-40, 150 mM NaCl, 1 mM EDTA 
plus protease inhibitors). After measuring protein concentration, the cell lysates 
containing 100 μg total proteins were mixed in IP binding buffer (20 mM Hepes-KOH, 
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0.1 mM KCl, 2 mM MgCl2, 15 mM NaCl, 0,2 mM EDTA, 1mM DTT, 10% glycerol). 
The HA-MAX protein was labeled with QD525-antibody through anti-HA rabbit 
polyclonal primary antibody and QD525-conjugated anti-rabbit IgG secondary antibody. 
The cell lysate from empty vector-transfected 293 cells that did not express HA-MAX 
was mixed with anti-HA polyclonal primary antibody plus QD525-conjugated anti-
rabbit IgG secondary antibody and used as a control sample (Figure 9). 
 
 
Figure 9. Sample protein preparation. (a) QD525 binds to MAX through primary antibody anti-HA. (b) 
MAX protein is associated with multiple QD525s due to anti-HA’s polyclonal nature. Identification of 
target protein from free QD525 in cell lysate mixture based on photon counts. 
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2.6 Characterization of 3D Hydrodynamic Flow Focusing 
The confocal fluorescent microscopy (Olympus FV1000) equipped with air-
cooled 543nm HeNe laser was used to characterize the 3D hydrodynamic flow focusing. 
Rhodamine B resolved in phosphate buffered saline (PBS) solution was injected through 
the analyte inlet and DI water was pumped through the sheath inlet to form the 3D flow 
focusing. The cross-sectional images were obtained at the 100 μm apart from the cross 
junction with different analyte and sheath flow conditions. The confocal microscope had 
60X water immersion objective (NA=1.2) and Z-stacked series of fluorescent images 
were taken at 0.53 μm intervals. In addition, a top view and a side view of the analyte 
stream in the detection channel were also characterized. 
 
2.7 Results and Discussion 
2.7.1 Characterization of Analyte Flow Profile 
In order to characterize the 3D hydrodynamic flow focusing of the analyte stream, 
the cross-sectional images were obtained by using the confocal microscope. 1M 
concentration of Rhodamine B dissolved in PBS solution was induced into the analyte 
inlet and DI water was pumped through the sheath stream inlet. The analyte flow rate 
(VAnalyte) and the sheath flow rate (VSheath) were independently controlled by two syringe 
pumps. The VAnalyte was set to 1 μl/min and the VSheath was also controlled from 10 
μl/min to 160 μl/min. Also, the cross sectional profiles were characterized at the 
different combinations of VAnalyte and VSheath (data was not shown). Figure 10 (a) showed 
the cross sectional view, top view and side view of fluorescent images of the analyte 
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stream at the flow condition of Vanalyte: 1 μl/min and to V sheath: 60 μl/min. Same as other 
flow conditions, the analyte stream was straight and uniform for 0.1 mm from the cross 
junction. Cross sectional images of the analyte stream with different flow conditions of 
analyte and sheath streams were shown at Figure 10 (b). From these images, it was 
obvious that the height of the analyte stream was reduced by increasing Vsheath, and the 
cross section of the analyte stream was generally deformed to a triangular shape. 
Because the depth of sheath channels was deeper than that of the analyte outlet channel, 
the analyte stream was pressured from three directions, i.e., top to down, left to right and 
right to left as shown in Figure 10 (a). As shown in Figure 10 (b), the analyte stream 
showed the large cross sectional area at the lower sheath flow rate.  
The sample flow cross-section diagram as a function of sheath and sample flow 
rates is shown in Figure 11. The sample flow rate was increased from 1 μl/min to 3 
μl/min at 0.5 μl/min steps and sheath flow rate was also changed according to sample 
flow rate increments. As mentioned earlier, in all cases, the cross-sectional shapes of 
sample flow showed sharp triangle at the lower sheath flow rate and flat triangle at the 
higher sheath flow rate. Also, the areas of sample stream were exponentially decreased.  
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Figure 10. Analyzing flow profile. (a) The concept of 3D focusing mechanism. (b) The cross-sectional 
profiles of rodamine B flow with different analyte and sheath flow rate (white dotted line: the wall of the 
channel). 
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Figure 11. The cross-sectional profile diagram as a function of sheath and sample flow rates. When the 
Vsheath is increased, sample stream cross section becomes smaller. Vsample is increased, sample stream shape 
becomes flatten. 
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The cross section with low sheath flow rate caused the distortion of photon burst 
histograms because the analyte stream was larger than that of the laser spot as described 
earlier. Also, there would be high possibility that multiple analytes pass through the 
detection spot simultaneously. In addition, the flat shaped analyte streams were also 
observed at the higher sheath flow rate. Although the vertical resolution was improved, 
the analyte stream was extended to x-direction and the width of analyte stream was still 
larger than laser spot. Moreover, higher flow velocities were avoided due to the 
limitation of sampling frequency of APD. By considering these two factors, the flow rate 
was optimized VAnalyte:VSheath =1:60 (μl/min) and used for the single molecule photon 
detections. Then, QD525-antibody in DI water was pumped through the analyte inlet and 
the laser was focused at the top of the triangular shaped analyte stream.  
Figure 12 (a) showed that the photon bursts which were obtained from QD525-
antibody sample solution for 10 seconds period (data shown in 20 μs interval). These 
photon bursts were correlated to obtain auto-correlation curve that was fitted by using 
non-linear fitting method,50-52 as shown in Figure 12 (b). The width of analyte stream 
and effective detection volume were calculated from the correlation curve fitting. The 
calculated width of analyte was 0.3 μm, and it was smaller than calibrated laser beam 
diameter (1.1 μm). This result indicated that the analyte flow was completely filled 
inside the laser beam path. The effective detection volume was estimated as 1.7 nL and 
this condition was used for all detections (Figure 12 (c)). 
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Figure 12. The effective volume of analyte stream. (a) Photon bursts graph as a function of time obtained 
from QD525 in 20 μs interval. (b) Fluorescent correlation fitting. (c) The effective volume area compared 
to calibrated laser spot (green square: the calibrated laser spot, white dotted line: the wall of the channel). 
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Figure 13. Flow velocity analysis (dotted line: total flow rate setting of syringe pump (61μl/min)). 
 
In order to analyze the stability of the flow, flow velocity data was acquired from 
photon bursts data of QD525 by Fluorescence Correlation Spectroscopy. Since the 
detection time was 10 seconds, constant velocities were obtained for all samples as 
shown in Figure 13.  
 
2.7.2 Quantitative Detection of QD525-antibody  
QD525-antibody analyte samples with different concentration were examined 
using the 3D hydrodynamic flow focusing microfluidic device. The original QD525-
antibody solution with 1μM was diluted 1/103 (1nM), 1/104 (100 pM) and 1/105 (10 pM) 
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times via PBS solution and these three samples were characterized with the flow 
condition of 1 μl/min (VAnalyte) and 60 μl/min (VSheath). Photon bursts for each QD525-
antibody concentration were shown in Figure 14 (a), (c) and (e) in 20 μs interval.  
It is obvious that more photon bursts were detected by increasing analyte 
concentrations. After the FFT filtering with 1 μs bin time, photon counts were 
normalized by 100 counts to 1.0. The histogram of normalized photon bursts were 
plotted as shown in Figure 14 (b), (d) and (f). The 1 μs bin time was determined by 
analyte residual time calculated from how long it took for analyte to pass through the 
detection volume. In these histograms, there were two distribution peaks. Because the 
first peaks showed Poisson distribution, these were defined as noise distributions from 
detection equipment and background. The second peaks in the histograms were defined 
as single molecule signals from QD525-antibodys due to their Gaussian distribution. In 
this histogram, the positions of secondary peaks were shifted because the background 
noise levels increased as following QD525-antibody concentration increase.  
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Figure 14. QD detection with different concentration. (a) Photon burst signal of QD at 10 pM in 20 μs 
interval. (b) Histogram of QD at 10 pM. (c) Photon burst signal of QD at 100 pM in 20 μs interval. (d) 
Histogram of QD at 100 pM. (e) Photon burst signal of QD at 1 nM in 20 μs interval (f) Histogram of QD 
at 1 nM. 
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The numbers of QD525-antibodys in the second peaks were counted and 
averaged for each result, then plotted as bar graphs with standard deviation as shown in 
Figure 15. It clearly showed that the numbers of detected QD525s were linearly 
increased with small standard deviation. Based on detected numbers of QD525-antibody, 
detection volume, and flow rate, the concentrations of QD525-antibody were calculated 
as 0.971 ± 0.024 nM, 131 ± 40 pM and 11 ± 5 pM for 1nM, 100pM and 10pM QD525-
antibody solutions, respectively. These results indicate that our system works properly to 
determine the protein concentrations since the calculated concentrations from obtained 
data are closed to original concentrations.  
 
 
Figure 15. The quantified graph of the number of detected QD with different concentrations and summary 
of the measured QD concentrations. 
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2.7.3 Quantitative Detection of HA-MAX 
Subsequently, the concentration of HA-MAX proteins in cell lysate solutions was 
also determined. 1 nM QD525-antibodies were hybridized to anti-HA rabbit polyclonal 
antibody specifically binds to HA tag of HA-MAX proteins. Thus, QD525-conjugated 
rabbit IgG secondary antibody recognize HA-MAX by binding anti-HA antibody. As a 
result, multiple QD525s could bind to HA-MAX proteins. As a first step, HEK293 cells 
without HA-MAX expression were lysed and characterized as a control. In this sample, 
there was no HA-MAX protein available for anti-HA antibody to recognize. Cell lysate 
solution mixed with QD525s-conjuated secondary antibody and PBS solution were 
pumped through the analyte and sheath inlets, respectively. Photon bursts for each 
sample were detected 5 times for 10 seconds. The typical photon bursts obtained from 
the control sample was shown in Figure 16 (a) in 20 μs interval. These peaks were from 
single QD525-antibodies and the photon burst histogram was plotted as shown in Figure 
16 (b). This histogram showed similar distribution compared to the one in Figure 15 (f) 
that contained a single Gaussian distribution. The number of detected QD525-antibodies 
in the Gaussian distribution was 958. HA-MAX expressed HEK293 lysate were 
hybridized with anti-HA-antibody and QD525s-conjugated secondary antibody for 
labeling. Figure 16 (c) showed the photon bursts of the HA-MAX expressed sample as a 
function of time (in 20 μs interval). Obviously, there was the photon burst that had 
higher photon counts than those in Figure 16 (a) because HA-MAX protein carried more 
than single QD525s. Individual photon bursts were plotted in the photon burst histogram 
as shown in Figure 16 (d). In this histogram, two obvious Gaussian peaks were obtained.  
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Figure 16. Results of HA-MAX detection. (a) Photon burst signal profile of vector in 20 μs interval. (b) 
Histogram of Vector. (c) Photon burst signal profile of HA-MAX in 20 μs interval. (d) Histogram of HA-
MAX. (e) Western blot result of the same samples. 
 
 30
The first Gaussian peak was concluded as unbound QD525-antibodies as proven 
in Figure 16 (b) and Figure 15. The second peak concluded as HA-MAX protein because 
HA-MAX protein had more than one QD525s. In this histogram, numbers of HA-MAX 
and unbound QD525 were counted as 347 and 674, respectively. The concentration of 
HA-MAX was determined as 0.283 ± 0.015 nM by considering detected events, 
detection volume, and flow rate. This process only requires for 1 minute. The expression 
of HA-MAX was also characterized by the conventional western blot, which required for 
24 hours of biochemical processes, as shown in Figure 16 (e). From the result of western 
blot, HA-MAX expression could be observed, but it did not provide quantitative 
information of HA-MAX concentration. 
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3. MEASUREMENT OF P-53 DIFFUSION USING RICS 
3.1 Introduction 
Analysis of protein-protein or protein-DNA interaction is indispensable for 
current molecular biology to understand various signaling pathways that are essential for 
maintenance of cellular functions in living cells. To this end, several biochemical and 
molecular biological techniques have been developed, such as far western blot,53 co-
immunoprecipitation,54 Mass spectrometry,55 electromobility shift assay (EMSA),56 and 
chromatin immunoprecipitation (ChIP).57 Although these techniques have their own 
advantages, they require long process time and a large amount of samples. More 
importantly, these techniques do not provide the information regarding the high spatial 
and temporal interaction dynamics that may provide the novel insight into current 
biology. Thus, several techniques, for example, Single Particle Tracking (SPT),58 
Fluorescence Recovery after Photo bleaching (FRAT),59 and Foster Resonance Energy 
Transfer (FRET),60, 61 have been developed to provide higher temporal/spatial resolution 
for molecular dynamics in living cells. Recently, Digman and co-workers introduced the 
new approach, called as Raster Image Correlation Spectroscopy (RICS), which enables 
to measure the protein dynamics in a living cell by using commercial laser scanning 
confocal microscope without adding additional expensive components. The detailed 
theories are described elsewhere.62-65  
______ 
Reprinted with permission from “Measurement of Protein 53 Diffusion Coefficient in 
Live HeLa Cells Using Raster Image Correlation Spectroscopy (RICS)”, by Sungmin 
Hong, Ying-Nai Wang, Hirohito Yamaguchi et al. Journal of Biomaterials and 
Nanobiotechnology 1, 31-36 (2010). Copyright 2010, Scientific Research. 
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The tumor-suppressor protein p53, that has been known as “the guardian of the 
genome,” is frequently mutated or deleted in variety of human cancer types and plays an 
essential role in tumorigenesis.66 In response to DNA damage, p53 is phosphorylated at 
several serine/threonine residues, resulting in its stabilization and activation.67 Activated 
p53 forms a complex with multiple transcription co-factors and binds to promoter 
regions of target genes such as p21, Bax GADD45 and Puma that are involved in cell 
cycle arrest or apoptosis.68, 69 Cisplatin and etoposide are DNA damaging agents that 
have been used as chemotherapeutic drugs. Cisplatin unwind intra- and interstrand 
crosslinking of DNA while etoposide disrupts DNA replication and repair by inhibiting 
topoisomerase II enzyme.70, 71 Thus, both anti-cancer agents damage to DNA that induce 
p53 accumulation and activation. 
 
3.2 Cell Culture and Drug Treatment 
Human cervical cancer, HeLa cells were obtained from American Type Culture 
Collection (ATCC) and maintained in DMEM/F12 medium supplemented with 10 % 
fetal bovine serum and antibiotics. pEGFP-C2 was obtained from Clontech laboratories. 
p53 Open Reading Frame was digested out from pcDNA3-myc-p53 with EcoRI and 
XhoI, and ligated into pEGFP-C2 EcoRI/SalI sites. pcDNA3-myc-p53 was prepared by 
polymerase chain reaction (PCR) and described previously.72 EGFP empty vector or 
GFP-p53 expression plasmid was transfected into HeLa cells using electroporation. 
After 24 hours transfection, the cells were seeded in 50 mm Glass Bottom culture dish 
(MatTek Corp.) at around 50 % density and cultured for additional 12 hours. Since our 
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preliminary experiments showed that over 50 M  drugs induced apoptotic cell death 
after 24 hours, the cell samples were treated or untreated with either 20 M cisplatin 
(Sigma) or 20 M etoposide (Sigma) for the different periods of time and subjected to 
confocal microscopy analysis. 
 
3.3 Confocal Microscope Setting 
The confocal fluorescent microscopy (Olympus FV100) equipped with air-
cooled 488nm argon ion laser was employed for this study (Figure 17). The series of 
images were collected using 60X water immersion objective (NA=1.2). The scan speed 
was set at 12.5 s/pixel. The scan area was 256 × 256 pixels and 100 frames were 
collected for each sample. The corresponding line and the frame time were 4.325 ms and 
1.150 s, respectively. 488 nm wavelength of laser with 1.5 % power was used for the 
GFP excitation, and emission spectrum was filtered between 500 and 600 nm. The 
microscope was operated in the pseudo photon counting mode. The beam waist radius 
was calibrated using 10 nM fluorescein in 0.01M NaOH at the beginning of experiment, 
and it was 0.5 μm. The collected fluorescence data were analyzed using the Globals 
software package developed at the Laboratory for Fluorescence Dynamics at the 
University of California at Irvine.73 
 
 34
 
Figure 17. Schematic diagram of system setting. 
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3.4 Results and Discussion 
3.4.1 GFP Diffusion Dynamics Analysis 
Figure 18 showed the RICS analysis for GFP alone in living HeLa cells 
immediately after adding cisplatin and etoposide. The diffusion coefficients were 
measured every 4 hours after adding the drugs. The GFP samples were used to calibrate 
the RICS analysis. The autocorrelation spectrum after background subtraction showed 
that GFP diffused freely into the nucleus. The measured diffusion coefficients of GFP 
were 38.26 ± 5.62 m2/s (cistplatin-treated) and 41.32 ± 9.81 m2/s (etoposide-treated) 
at the 0 hour. Also, consistent values were observed over time (43.73 ± 6.57 m2/s and 
44.36 ± 6.82 m2/s at the 16 hour) as shown in Table 2. 
 
Table 2. Summary of GFP diffusion coefficient in the nuleus of HeLa cells 
 Diffusion Coefficient (μm
2/s) 
 0 hr 4 hr 8 hr 12 hr 16 hr 
Etoposide 41.32±9.81 36.54±6.61 41.21±8.29 44.72±8.97 44.36±6.82 
Cisplatin 38.26±5.62 37.55±5.67 42.65±9.46 44.72±9.14 43.73±6.57 
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Figure 18. RICS analysis of GFP in live HeLa cells at after anti-cancer drugs treatment. (a) Optical 
images of HeLa cell with the region of interest (ROI) for RICS analysis, (b) intensity images of ROI 
(nucleus), (c) RICS autocorrelation function of 128×128 pixels, (d) fit (lower surface) and residues (upper 
surface) of the spatial correlation function. 
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To compare the dynamics of p53 in response to DNA damaging agents, HeLa 
cells expressing GFP-tagged p53 were exposed to cisplatin or etoposide and subjected to 
RICS analysis. We first collected 100 frame images of GFP-p53 immediately after drugs 
treatment. Following, GFP-p53 in HeLa cells treated with the drugs were monitored 
every 4 hours upto 16 hours.  
 
3.4.2 GFP-P53 Diffusion Dynamics Analysis 
Figure 19 showed the auto-correlation of confocal images and fitting of the 
spatial correlation function at 16 hours after drugs treatment.  These results suggest that 
GFP-p53 interacts with other molecules such as proteins and DNAs after the drug 
treatment and, as a result, the diffusion coefficients were reduced. The diffusion 
dynamics changes of GFP-p53 in response to the drugs were summarized in Table 3. 
 
Table 3. Summary of GFP-p53 diffusion coefficient in the nuleus of HeLa cells 
 
Diffusion Coefficient (μm2/s) 
 
0 hr 4 hr 8 hr 12 hr 16 hr 
Etoposide 18.76±2.68 12.77±5.42 3.05±0.60 3.57±1.08 3.25±1.36 
Cisplatin 19.92±3.64 8.23±5.78 3.25±0.38 3.21±1.18 3.28±2.87 
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Figure 19. RICS analysis of GFP-p53 in live HeLa cells at 16 hours after anti-cancer drugs treatment. (a) 
optical images of HeLa cell with the region of interest (ROI) for RICS analysis, (b) intensity images of 
ROI (nucleus), (c) RICS autocorrelation function of 128×128 pixels, (d) fit (lower surface) and residues 
(upper surface) of the spatial correlation function. 
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As shown in Figure 20, the measured diffusion coefficients of GFP-p53 were 
19.92 ± 3.64 m2/s and 18.76 ± 2.68 m2/s immediately after adding cisplatin and 
etoposide, repectively, and these results were in a good agreement with previous 
reported result (15.4 ± 5.6 m2/s) 74. The diffusion dynamics of GFP-p53 were gradually 
decreased over time, and significant reductions of GFP-p53 mobility were observed at 8 
hr after drugs injection, (3.25 ± 0.38 m2/s for cisplatin and 3.05 ± 0.60 m2/s for 
etoposide).Then, it maintained the constant values after 8 hr in the presence of both 
drugs.  
In this work, we measured the diffusion coefficient of GFP-tagged p53 in the 
nucleus of HeLa cells using RICS approach. Also, DNA damaging agents were used to 
verify p53 dynamics in response to DNA damage. The diffusion coefficients of GFP 
obtained by RICS were agreed well with previously reported value. Hinow et al. applied 
free diffusion model to explain the mobility of GFP in the nucleus of H1299 human 
large cell lung carcinoma cell using confocal FRAP technique, and they reported the 
diffusion coefficient of GFP (41.6 ± 13.6 m2/s).75 
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Figure 20. The diffusion coefficient graph as a function of time. (a) diffusion dynamics changes of GFP or 
GFP-p53 in cisplatin treated cells, (b) diffusion dynamics changes of GFP or GFP-p53 in etoposide treated 
cells. 
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Since GFP was not involved in DNA damage response, the diffusion of GFP was 
not affected by anti-cancer drugs. This demonstrated that RICS method could provide 
the stable result in measuring diffusion coefficient in living HeLa cells. After DNA 
damaging agent treatment, the significant reductions in GFP-p53 mobility were observed 
in the nucleus. It is well known that p53 is stabilized and activated  in response to DNA 
damage.76 In this study, 20 M concentrations of cisplatin and etoposide were used. It 
would be expected that higher concentration of drugs induces the quicker reduction of 
the mobility of GFP-p53 due to the p53 activation by more DNA damage. Furthermore, 
it has been known that ciplatin induces single stranded break of DNA77 while etopside 
causes double stranded break of DNA.78 Thus, the combination of these drugs induces 
more DNA damage, and it also would be expected that the combination of both drugs 
induces the quicker reduction of the mobility of GFP-p53. 
Moreover, it has been shown that p53 translocates from cytosol to the nucleus 
after DNA damage. Activated p53 form a complex with multiple transcriptions co-
factors and binds to the specific promoter region in DNA to induce target genes within 8 
hours. As a result, p53 mobility was expected to be decreased. Our results for 
fluctuations of GFP-p53 diffusion coefficients were consistent with our prediction from 
the current knowledge regarding p53. 
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4. MICROFLUIDIC INTEGRATED PLATFORM 
4.1 Introduction 
Cell-containing microspheres are widely used as building blocks in many 
biomedical applications such as tissue engineering,79-82 cell-based biosensors,83-85 and 
encapsulated cell delivery.86-88 These applications require uniform microsphere 
dimensions and morphology with high cell viability. Live cells are typically 
encapsulated in biodegradable polymers such as alginate,89, 90 polyethylene glycol 
(PEG),91 and collagen92, 93 that are highly porous, allowing adequate transport of 
nutrients and oxygen to the cells. Collagen is a particularly attractive material for 
microspheres as it is the most abundant scaffold protein in tissues94 and contains specific 
cell-binding sites that contribute to normal cell function.95 
Collagen microspheres are commonly generated by first forming microdroplets 
of cells in collagen via direct aliquoting or via emulsification, and subsequently 
microspheres are formed via gelation of the collagen. Currently, there is no report 
regarding the generation of collagen microspheres in microfluidic devices. Aliquoting 
involves dispensing small volumes (a few microliters) of aqueous collagen solution onto 
a surface.87, 96-98 In emulsification, aqueous collagen solution is dispersed into 
microdroplets within a continuous oil phase solution.99, 100 The emulsified microspheres 
are then typically separated from the oil phase by centrifugation.101 These conventional 
approaches are tedious, requiring that each step (i.e. droplet generation, gelation, and 
extraction) be performed separately. Another drawback of these techniques is the 
difficulty in maintaining uniform microsphere dimensions and shapes at a high 
 43
production rate. Recently, an axisymmetric flow-focusing device (AFFD) was 
developed102 to generate collagen microspheres. The mono-dispersed collagen 
microdroplets were generated at the orifice of a nozzle in the AFFD and collected in a 
test tube. The collected collagen microdroplets were gelled at 37°C for 45 min. Due to 
the forces generated during centrifugal extraction, the dimensions and shapes of the 
resulting collagen microspheres were non-uniform due to coalescence of microdroplets. 
In addition, low cell viability was observed that was attributed to the centrifugation 
process.101 The bioprinting platform also produced cell encapsulated collagen 
droplets.103 This approach enables multilayered 3D cell-laden hydrogel structures, high-
throughput droplet generation, and long-term viability; however, the shapes of collagen 
droplets would not be spherical due to gravity.  
 
4.2 Droplet Generation Techniques 
4.2.1 T-junction Geometry 
 T-junction structure is the most widely used for the droplet generation because it 
has the simplest geometry and mechanism.104, 105 As shown in Figure 21, droplets are 
generated by shear force of a continuous flow (normally used oil), which is connected 
perpendicularly to disperse phase (normally water). The disperse flow was cut off by 
vicious drag force of the continuous flow and generate droplets. The size of the droplets 
are able to control by the flow rate changes and the channel dimensions. 
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Figure 21. The principle of droplet formation at a T-junction.105 
 
4.2.2 Hydrodynamic Flow Focusing 
Another method for droplet generation is a hydrodynamic flow focusing.106-108 A 
hydrodynamic flow focusing device has two side channels which contain continuous 
phase and a main channel contains dispersed phase. The continuous phases from side 
channels are forced aqueous dispersed phase to flow to the narrow orifice and the 
dispersed phase breaks off by pressure and viscous stresses (Figure 22).  Similarly, the 
droplet size is adjustable by flow rate control, channel dimension, and orifice size. 
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Figure 22. Basic flow focusing setup with a disperse phase and a continuous phase. 
 
4.3 Device Fabrication 
Microfluidic devices were fabricated on poly (dimethylsiloxane) substrate 
(PDMS; Dow Corning, Midland, MI) by standard micro-molding procedures.48, 110, 111 
Two lithographic processes fabricated a master mold of a microfluidic chip on a silicon 
wafer. First, SU-8 2075 photoresist (Microchem Corp., Newton, MA) was spin-coated 
with thickness of 100 m on a silicon wafer. Shallow microchannels for microsphere 
extractions were defined by a contact aligner. As the second lithographic process, a SU-8 
2075 layer of 300 m thickness was spin-coated on top of the shallow channel-patterned 
silicon surface and defined as a deep main channel that was directly connected to the 
shallow channels to form a step junction structure. The top channel master mold was 
also fabricated, which contained the pre-warmed mineral oil injection port. As the final 
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step, uncured PDMS polymer solution was dispensed over the lithographically patterned 
silicon molds and cured at 65 C° for 2 hours.  The microfluidic chip consists of three 
layers of PDMS substrate. The top PDMS layer contains the pre-warmed mineral oil 
delivery port and an extraction chamber. The main channel structure is located in the 
second PDMS layer, and third layer contains the collagen microsphere extraction 
chamber (Figure 23). These three PDMS layers and a bottom glass substrate (170 m 
thickness) were bonded after oxygen plasma treatment. 
 
4.4 Preparation of Collagen-MDA 231 Mixture 
The human breast cancer cell line MDA-MB-231 expressing Green Fluorescent 
Protein (GFP) was cultured in Dulbecco’s Minimal Essential Medium (DMEM)/F12 
medium supplemented with 10% fetal bovine serum (FBS). Cells were cultured in a 
humidified 5% CO2/95% air incubator at 37°C. Cells were removed with trypsin-EDTA 
from the culture dish and centrifuged. A 1×108 cells/ml concentration of MDA 231 cells 
was suspended in rat tail collagen type 1 solution at a concentration of 3.5 mg/ml as 
previously described.112-114 
 
 47
 
Figure 23. The configuration of the microfluidic platform consisting of three PDMS and one glass 
substrates, all of which are bonded. 
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4.5 Coaxial Cooling System 
 In order to maintain collagen temperature below 4°C to avoid premature collagen 
gelation, coaxial cooling system was applied as shown in Figure 24. 1mL syringe was 
surrounded by plastic tubing which contained frozen refrigerant gel, and connected to 
cylindrical coaxial cooling tube. Metal tubing was placed in the center of cooling tube 
and larger plastic tubing was covered on metal tubing. It also had refrigerant gel inside 
of plastic tubing and was kept in the -20°C refrigerator before using this system. By 
using this cooling system, collagen was able to deliver to microfluidic platform over 
1hour without collagen gelation.  
 
Figure 24. Coaxial cooling system. (a) The schematic diagram: 1. 1mL syringe, 2. refrigerant gel,  
3. collagen solution, 4. metal tubing, and 5. tygon tube. (b) photography of cooling system. 
 49
4.6 Collagen Microspheres Formation 
A schematic diagram and photograph of the microfluidic platform are shown in 
Figure 25 (a) and (b), respectively. The pre-mixture of collagen and cell solution was 
delivered via the collagen injection port as shown in Figure 25. The temperature of the 
collagen solution was maintained below 4ºC using coaxial cooling tubing, allowing 
stable pumping of the collagen solution by avoiding premature collagen gelation for 
more than 1 hour.  
Collagen solution and cold mineral oil were injected with two separate syringe 
pumps (11 plus, Harvard Apparatus, Cambridge, MA). A 2% concentration of Span 80 
(surfactant) was added to the mineral oil to facilitate droplet stabilization. At the T 
junction, shear forces from the mineral oil flow periodically separated the collagen flow 
into discrete collagen microdroplets. The two-phase flow was blended with pre-warmed 
mineral oil (40°C) in the gelation channel through interconnection holes. The relatively 
wide gelation channel (2 mm) allowed collagen microdroplets to spontaneously form 
spherical shapes by minimizing aqueous-oil phase surface interactions. Collagen 
microspheres continuously flowed through the gelation chamber to prevent adhesion to 
the walls and collected in a deep extraction chamber containing a filter gate.  
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Figure 25. The design of the microfluidic chip. (a) The schematic diagram of microfluidic chip that 
contained three functional channels: droplet generation, gelation and extraction. (b) Actual photo of a 
PDMS chip. 
 51
Once all collagen microspheres were collected, mineral oil flow was terminated 
and culture media (indicated by pink color in Figure 26 (a)) was injected through a local 
injection port to remove mineral oil from collagen microspheres. The rotary pump 
connected to the extraction chamber continuously sucked solution from the chamber and 
culture media was continuously pumped in to wash any remaining mineral oil on the 
surface of collagen microspheres for 3 minutes. The filter gate consisted of multiple 
microchannels with 100 um width and depth that were smaller than the diameter of the 
microspheres (Figure 26 (b)). Microspheres were collected from the chip using a 
micropipette after all flows were terminated. The extracted microspheres were 
transported to sterile culture dishes and incubated at 37°C in a humidified 5% CO2 
incubator. Our approach provides straightforward and high throughput generation of 
uniform collagen microspheres encapsulating cells with high viability. 
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Figure 26. The design of the extraction chamber. (a) The extraction chamber (close-up view) (b) The 
SEM image of filter gates. 
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4.7 Collagen Microspheres Extraction System 
The detailed schematic diagram for the extraction of collagen microspheres from 
oil phase is shown in Figure 27. Collagen microspheres are collected in the extraction 
chamber and incubated until the completion of droplet generations. After termination of 
droplet generations, culture media was pumped through the injection port. Culture media 
is filled from the bottom of the extraction chamber due to heavier density. The mineral 
oil is pimped to the top and sucked to the left side of chamber by the vacuum pump. 
Finally, all oil phase is replaced to aqueous media (culture media) and microspheres are 
collected by pipette. 
 
 
Figure 27. Collagen microspheres extraction. (a) Collagen microdroplets were generated. (b) 
Microspheres were collected in extraction chamber. (c) Culture media was injected. (d) Mineral oil 
separation by density. (e) Mineral oil removing by vacuum suction. (f) Collagen microspheres in 
extraction chamber. 
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4.8 Overall System Setup 
The microfluidic platform was placed on the Nikon Eclipse Ti-U Inverted 
microscope stage as shown in Figure 28. Four individual syringe pumps were used to 
deliver mineral oil, collagen solution, pre-warmed mineral oil, and culture media. Also, 
rotary pump was used for mineral oil extraction. Fluorescence light (lumen 200) was 
focused through the objective lens at the observation spot of droplet generation area.  All 
images were recorded by emccd and microscope software. 
 
 
Figure 28. System setup for collagen microspheres generation. 1: computer, 2: monitor, 3: fluorescence 
light source, 4: inverted microscope, 5-8: syringe pumps to deliver each solution, 9: rotary pump for oil 
extraction.  
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4.9 Results and Discussion 
4.9.1 Collagen Microspheres Diameter Analysis 
Figure 29 and Table 4 summarize the capabilities of the device to produce 
monodisperse collagen microdroplets with controlled sizes. To achieve different sizes, 
the collagen solution flow rate was fixed at 3 μL/min while mineral oil flow rate was 
varied. As shown in Figure 29, monodisperse droplets were formed at each oil flow rate 
with the diameter linearly decreasing from 306.82 ± 1.78 μm to 103.26 ± 1.2 μm as the 
oil flow rate was increased from 10 to 50 μL/min. In addition to decreasing droplet size, 
increasing the oil flow rate also increased the rate of droplet generation (Figure 30). 
 
Table 4. Summary of collagen droplet size at each oil flow rate. 
 Oil Flow Rate (μL/min) 
 10 20 30 40 50 
Size of 
droplets 
306.82±1.78 250.10±1.73 205.04±1.93 150.14±1.98 103.26±1.20 
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Figure 29. Effect of oil flow rate on droplet diameter. Upper: optical images size distributions of droplets 
generated with mineral oil flow rate of 10, 30, and 50 μL/min (while collagen flow rate was fixed at 3 
μL/min). Lower: droplet diameter decreases with increasing oil flow rate.  
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Figure 30. Collagen microspheres characterization. Droplet generation rate (droplets per minute) increases 
with increasing oil flow rate. 
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4.9.2 Cells Encapsulated in Collagen Microspheres 
Collagen-cell solutions were prepared with a range of concentrations of MDA 
231 cells.  The flow rates of collagen and oil were set as 3 and 30μL/min, respectively, 
resulting in 200 μm diameter collagen droplets. The average number of cells 
encapsulated in collagen microspheres was 107±23 at a concentration of 1 × 108 
cells/mL. When the cell concentration was lower than 1 × 105 cells/mL, single cell was 
encapsulated (some of the droplet had no cell and empty droplets were not counted), and 
multiple cells were captured at the higher concentration (Figure 31). 
 
 
Figure 31. The analysis of MDA 231 cell encapsulation rate. Upper: Fluorescence images of GFP-
expressing cells in collagen microspheres (scale bar: 200 μm). Lower: Summary plot of encapsulated cell 
number per sphere at different cell concentrations in the cell-collagen solution. 
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4.9.3 Collagen Gelation at Different Incubation Temperatures  
Collagen fiber configuration may affect incorporated cell viability and 
proliferation. In order to verify collagen gelation in a microfluidic chip, collagen 
droplets were gelled at different temperatures (4, 25, and 37°C). The collagen droplets 
generated with each condition were collected on a sterile petri-dish and collagen fibrils 
were imaged by confocal reflection microscope using a 60× water immersion lens. As 
shown in Figure 32, no collagen fibers were observed in microspheres gelled at 4°C, 
while only a small number of fibers were observed when the gelation temperature was 
increased to 25 °C.  At 37°C, collagen fibers were readily apparent.   
 
 
Figure 32. Fluorescence images of collagen fiber at different incubation temperatures. (a) Incubation at 
4°C. (b) Incubation at 25°C. (c) Incubation at 37°C. The bright dot in the center of the image is an artifact 
of confocal reflectance. Scale bar: 5 μm. 
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4.9.4 Collagen Microspheres Formation and Throughput 
As mentioned previously, the microfluidic platform was able to produce 
microdroplets with diameters ranging from 50 μm to 300 μm with standard deviations of 
~2% at each size. The highest production rate was 200 droplets per minutes while 
applying a low oil flow rate, though the production rate can be easily increased by 
increasing the oil and aqueous flow rates.  
In our microfluidic platform, collagen gelation occurred immediately after the 
droplet generation process. Figure 33 shows bright-field microscopy images and 
diameter distributions of collagen microdroplets and resulting microspheres, illustrating 
that the collagen microsphere diameter decreased after gelation. Diameter distributions 
among 100 microspheres before and after gelation in the microfluidic chip were also 
shown in Figure 33. Dotted line in the microscope image on the upper right side showed 
the original dimension of collagen microdroplet before gelation process. A ~6% 
reduction in diameter of collagen microspheres was observed after gelation. The final 
average diameter of the collagen microspheres was 272 ± 12.6 μm.  
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Figure 33. Diameter changes of collagen microdroplets before and after gelation. Scale bar: 100 μm. 
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4.9.5 Microfluidic Platform and Conventional Methods 
A major advantage of our microfluidic platform over other existing methods for 
generating collagen microspheres is that collagen gelation takes place in confined 
structures immediately after droplet formation. This process avoids microsphere 
coalescence. Figure 34 shows a comparison of collagen microspheres generated by the 
microfluidic chip (collected at the extraction chamber) and a conventional emulsification 
approach in a test tube.115-117 While the microspheres generated in the chip were uniform, 
the diameters of collagen microspheres generated by emulsification were not since 
multiple collagen microspheres often coalesced to form larger spheres. Evidently, 
collagen gelation immediately after droplet generation in the chip results in virtually no 
coalescence among microdroplets. 
 
 
Figure 34. A comparison of collagen microspheres generated by our microfluidic chip (a) and in mineral 
oil made by emulsification (b). Scale bar: 200 μm. 
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4.9.6 Microdroplet Deformations by Centrifugation 
 We have observed deformation and collapse of collagen microspheres when they 
are extracted by centrifugation. As shown in Figure 35, deformed and agglomerated 
collagen microspheres were found after centrifugation process at the speed of 3000 
rpm/min for 15 min, which is a typical speed and duration of centrifugation employed to 
separate collagen microspheres from the oil phase. 
 
 
Figure 35. Optical images of malformed collagen microspheres. (a) Shape deformation of a single 
microsphere. (b) Agglomeration of multiple microspheres. 
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4.9.7 Encapsulated Cell Viability and Proliferation 
The cell viability in microspheres generated within the chip and via 
emulsification-centrifugation was compared. As shown in Figure 36, the amount of GFP 
fluorescence in collagen microspheres after extraction by our approach was about 93%, 
compared to 48% by centrifugation, indicating a significant difference in cell viability. 
This difference is likely attributable to the high compressive force cells experience 
during centrifugation which results in collapse of at least some collagen microspheres as 
previously shown in Figure 35. 
To characterize the fate of the encapsulated cells, we quantified changes in GFP 
fluorescence intensity over time. GFP-expressing MDA 231 cells encapsulated in 
collage microspheres with diameters of 300 μm diameters were generated by the 
microfluidic platform and by the conventional centrifugation method. All microdroplets 
made by both approaches were incubated in culture media at 37° in a 5% CO2 
environment. Fluorescent images of these samples as a function of time were shown in 
Figure 37 (a).The fluorescence intensities of cells in microspheres as a function of time 
were shown in Figure 37 (b). It was evident that the numbers of cells in both samples 
increased, strongly indicating that MDA 231 cells were viable in microspheres generated 
by the microfluidic platform. The proliferation of cells in microspheres generated by our 
approach was substantially more rapid than those in microspheres generated by the 
conventional extraction method. 
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Figure 36. Fate of cells encapsulated in collagen microspheres. Upper: Fluorescent images of 
microspheres extracted in the microfluidic chip (left) and by centrifugation (right). Lower: Cell viability 
rates in 100 microspheres extracted by the two methods are summarized based on their fluorescence 
intensities. 
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Figure 37. Encapsulated cell viability and proliferation (a) Fluorescent images of collagen microspheres 
encapsulated with MDA 231 cells by our method and conventional extraction method as function of time. 
Upper: Microspheres generated by the microfluidic platform (scale bar: 100 μm). Bottom: Microspheres 
generated by the conventional centrifugation (scale bar: 100 μm). (b) Fluorescence intensities in 
microspheres as a function of time. 
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5. CONCLUSIONS AND SUMMARY 
We have developed the microfluidic 3D hydrodynamic flow focusing device and 
determined the concentrations of QD525-antibodies and QD525/HA-MAX by using the 
confocal single molecule detection system. The 3D hydrodynamic flow focusing could 
compress an analyte stream and formed a triangular cross sectional profile with sharp top 
angle, which could not be achieved by the conventional flow focusing methods. Since 
the width of the analyte flow was compressed three dimensionally to 0.3 μm at the top of 
triangular shaped analyte stream by the sheath flow, it could be filled inside of laser 
beam path. As a result, Gaussian photon burst histograms were obtained for each analyte. 
The number of analytes obtained from Gaussian photon burst histograms, detection 
volume and flow rate, the concentration of analyte were determined. Currently, it is very 
difficult to determine the concentration of proteins directly from biological sample such 
as cancer cells. This approach provided a novel method to determine the concentration 
of target proteins that requires only 1 minute analysis time for each sample, which is 
greatly improved in comparing with conventional IP/Western blot or Liquid 
Chromatography.  
The diffusion coefficients of GFP-p53 in live HeLa cells have successfully 
measured by using commercial confocal microscope to RICS analysis method. RICS is 
able to measure protein diffusion in live cells using regular confocal microscope and 
require relatively short period of time. Therefore, it may be applied to a large-scale, high 
throughput drug screening based on the activation or inactivation of tumor suppressors 
or oncogene products in the future. 
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A microfluidic material processing platform has developed to generate collagen 
microspheres with encapsulated cells. Droplet generation, gelation and extraction were 
integrated into a single chip. Importantly, microdroplets were gelled immediately after 
their generation, which significantly improved microsphere dimension uniformity. In 
addition, our microfluidic extraction approach resulted in greater cell viability compared 
to that in microspheres extracted by the conventional centrifugation approach. High cell 
viability and uniformity of collagen microspheres demonstrated by our microfluidic 
platform will facilitate the development of the next generation of biomedical cell 
delivery or tissue engineering applications in the near future. 
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APPENDIX A 
 Detailed process flow for 3D hydrodynamic microfluidic device for rapid protein 
concentration analysis. 
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APPENDIX B 
 Confocal microscope setting for Raster Image Correlation Spectroscope (RICS). 
1. Objective lens: 60X water immersion lens 
2.  Pixel dwell time: 12.5 s 
3.  Line time:  4.325 ms 
4.  Frame time: 1.150 s 
5.  Pixel size: 0.05 m 
6.  Beam radius (): 0.2 m  
7.  All images were taken at 170 m above the cover slip 
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